The origin of the Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) has puzzled scientists.
Ever since the illness first came to light in the early 1980s. The first recognized cases of AIDS were recorded in the United States (U.S.) in the early 1980s.
HIV vaccine development and testing are known to be cost-intensive and time-consuming. In fact, a goal that was once seen to be easily within reach has over the years become fraught with various challenges, including genetic diversity of the virus, inadequate animal models for testing and a lack of understanding of correlates of risk.
An estimated 3.6 per cent of the Nigerian population is reported to be living with HIV and AIDS. Although HIV prevalence is much lower in Nigeria than in other African countries such as South Africa and Zambia, the size of Nigeria’s population (around 162.5 million) means that by the end of 2009, there were an estimated 3.3 million People Living With HIV (PLWH).
Even if the world eventually develops an HIV/AIDS vaccine, it may not be applicable to Nigeria because the country has a peculiar HIV type that needs its own vaccine.
NG Newspapers Free Email Subscription
Category: Health News in Nigeria